Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 35,000 shares at $180.29 ($6.4M) on 2015-11-25, disclosed to the SEC on 2015-11-30.
Scheduled sale ($6.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $180.29 | 5,601 | $1.0M | 15.9% |
| 2 | $181.47 | 7,774 | $1.4M | 22.2% |
| 3 | $182.45 | 21,125 | $3.9M | 60.5% |
| 4 | $182.96 | 500 | $91K | 1.4% |
| Total | $181.89 avg | 35,000 | $6.4M | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |